ALLIANCEBERNSTEIN L.P. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$133,000
-37.9%
49,700
+0.4%
0.00%
Q4 2021$214,000
-16.7%
49,500
-1.8%
0.00%
Q3 2021$257,000
-28.8%
50,400
-11.7%
0.00%
Q2 2021$361,000
-0.3%
57,100
+22.0%
0.00%
Q1 2021$362,000
-12.1%
46,800
-25.6%
0.00%
Q4 2020$412,000
-1.4%
62,9000.0%0.00%
Q3 2020$418,000
-22.0%
62,900
-2.3%
0.00%
Q2 2020$536,000
+8.5%
64,4000.0%0.00%
Q1 2020$494,000
+1.0%
64,400
+9.5%
0.00%
Q4 2019$489,000
-54.8%
58,800
-59.9%
0.00%
-100.0%
Q3 2019$1,082,000
-42.6%
146,637
-12.7%
0.00%0.0%
Q2 2019$1,885,000
+4.4%
167,9870.0%0.00%0.0%
Q1 2019$1,806,000
+21.9%
167,987
+71.3%
0.00%0.0%
Q4 2018$1,481,000
-18.4%
98,0700.0%0.00%0.0%
Q3 2018$1,814,000
-19.1%
98,0700.0%0.00%
-50.0%
Q2 2018$2,242,000
+6.1%
98,070
+32.0%
0.00%0.0%
Q1 2018$2,113,000
+22.1%
74,270
-9.4%
0.00%
+100.0%
Q4 2017$1,731,000
+29.3%
81,990
+11.3%
0.00%0.0%
Q3 2017$1,339,000
+17.3%
73,6900.0%0.00%0.0%
Q2 2017$1,142,000
+91.0%
73,690
+113.0%
0.00%
Q1 2017$598,00034,6000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders